IFNL4 ss469415590 Variant Is Associated with Treatment Response in Japanese HCV Genotype 1 Infected Individuals Treated with IFN-Including Regimens

Aim. Eradication of hepatitis C virus (HCV) is still challenging even if interferon- (IFN-) free regimens with direct-acting antiviral agents (DAAs) for HCV-infected individuals are available in clinical practice. IFNL4 is a newly described protein, associated with human antiviral defenses. We inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyamura, Tatsuo, Kanda, Tatsuo, Nakamoto, Shingo, Arai, Makoto, Nakamura, Masato, Wu, Shuang, Jiang, Xia, Sasaki, Reina, Haga, Yuki, Yasui, Shin, Ooka, Yoshihiko, Chiba, Tetsuhiro, Imazeki, Fumio, Mikami, Shigeru, Yokosuka, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274707/
https://www.ncbi.nlm.nih.gov/pubmed/25548683
http://dx.doi.org/10.1155/2014/723868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274707/
https://www.ncbi.nlm.nih.gov/pubmed/25548683
http://dx.doi.org/10.1155/2014/723868

Ejemplares similares